Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402607 | 0.92 | — | — | |
| SCHEMBL405902 | 0.91 | — | — | |
| SCHEMBL1109597 | 0.91 | MEN1 (0.43) | MEN1KMT2A | |
| SCHEMBL401072 | 0.89 | PPARG (0.40) | — | |
| SCHEMBL405243 | 0.88 | — | — | |
| SCHEMBL403991 | 0.88 | — | — | |
| SCHEMBL1105550 | 0.88 | — | — | |
| SCHEMBL403188 | 0.88 | — | — | |
| SCHEMBL1105535 | 0.88 | — | — | |
| SCHEMBL404786 | 0.88 | ALDH1A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9752056-B2 | Radiation-curing, water-dispersible polyurethane (meth)acrylates | BASF SE (DE) | 2017-09-05 | — | — | US | disclosed |
| US-20150225606-A1 | RADIATION-CURING, WATER-DISPERSIBLE POLYURETHANE (METH)ACRYLATES | BASF SE (DE) | 2015-08-13 | — | — | US | disclosed |
| EP-1618087-B1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2012-06-13 | — | — | EP | disclosed |
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8101640-B2 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-8084615-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2011-12-27 | — | — | US | disclosed |
| US-7989660-B2 | BACTERICIDE AGAINST GRAMNEGATIVE BACTERIA; RESPIARATORY SYSTEM DISORDERS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2011-08-02 | — | — | US | disclosed |
| US-7989660-B2 | BACTERICIDE AGAINST GRAMNEGATIVE BACTERIA; RESPIARATORY SYSTEM DISORDERS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2011-08-02 | — | — | US | disclosed |
| US-20110172174-A1 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS INC. | 2011-07-14 | — | — | US | disclosed |
| US-7358359-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2008-04-15 | — | — | US | disclosed |
| US-7358359-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2008-04-15 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-7169841-B2 | Curable aqueous polyurethane dispersions | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20060154988-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2006-07-13 | — | — | US | disclosed |
| US-20050025903-A1 | Radiation-hardened coatings with improved adhesive strength | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-03 | — | — | US | disclosed |
| US-20030153673-A1 | Curable aqueous polyurethane dispersions | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-14 | — | — | US | disclosed |
| US-4454301-A | POLYMER FROM ALKYL ACRYLAMIDOGLYCOLATE ALKYL ETHERS OR ACRYLAMIDOGLYCOAMIDE ALKYL ESTERS | AMERICAN CYANAMID COMPANY (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0096230-A1 | Crosslinking coating compositions | AMERICAN CYANAMID COMPANY (US) | 1983-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244197-A1 | Antibacterial agents | MRPL21, SI, PGLS | MEN1 2414/4885KMT2A 4800/4885 |
| US-20110172174-A1 | Antibacterial agents | MRPL21, SI, PGLS | MEN1 2414/4885KMT2A 4800/4885 |
| US-20060154988-A1 | Antibacterial agents | MRPL21, SI, PGLS | MEN1 2414/4885KMT2A 4800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.